Anders Persson

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Inference and analysis of cell-cell communication using CellChat

Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy

Functional decline in elderly patients presenting with acute coronary syndromes: Impact on midterm outcome

Universal Definition of Myocardial Infarction: Clinical Insights

Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation

Fourth Universal Definition of Myocardial Infarction (2018)

Wnt5a is elevated in heart failure and affects cardiac fibroblast function

The Lifelong Effects of Early Childhood Adversity and Toxic Stress

Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

Atherosclerosis

Revolutionizing healthcare: the role of artificial intelligence in clinical practice

Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents

Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Exercise-based cardiac rehabilitation for coronary heart disease

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Fourth Universal Definition of Myocardial Infarction (2018)

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Fourth universal definition of myocardial infarction (2018)

Predictive Model Based on Health Data Analysis for Risk of Readmission in Disease-Specific Cohorts.

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

C‐reactive protein, interleukin‐6, secretory phospholipase A₂ group IIA and intercellular adhesion molecule‐1 in the prediction of late outcome events after acute coronary syndromes

Long-term prognostic value of mitral regurgitation in acute coronary syndromes